205 related articles for article (PubMed ID: 8797581)
1. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R
Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
Powell CT; Fair WR; Heston WD
Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
[TBL] [Abstract][Full Text] [Related]
3. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
4. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
Jiang J; Kulp SK; Sugimoto Y; Liu S; Lin YC
Anticancer Res; 2000; 20(6B):4591-7. PubMed ID: 11205308
[TBL] [Abstract][Full Text] [Related]
5. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
Mohler JL; Levy F; Sharief Y
Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730
[TBL] [Abstract][Full Text] [Related]
6. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
7. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
Isaacs JT; Yu GW; Coffey DS
Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
[TBL] [Abstract][Full Text] [Related]
8. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
10. The effect of castanospermine on the metastatic properties of prostate cancer cells.
Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
Evans CP; Elfman F; Parangi S; Conn M; Cunha G; Shuman MA
Cancer Res; 1997 Aug; 57(16):3594-9. PubMed ID: 9270033
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
Hrzenjak M; Shain SA
Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
[TBL] [Abstract][Full Text] [Related]
17. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
18. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells.
Nwankwo JO
Anticancer Res; 2002; 22(6C):4129-35. PubMed ID: 12553043
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
Rabbani SA; Gladu J
Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
